These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 15669671)

  • 1. Neuropsychological outcome of subjects participating in the PKU adult collaborative study: a preliminary review.
    Brumm VL; Azen C; Moats RA; Stern AM; Broomand C; Nelson MD; Koch R
    J Inherit Metab Dis; 2004; 27(5):549-66. PubMed ID: 15669671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurocognitive functioning in adults with phenylketonuria: results of a long term study.
    Weglage J; Fromm J; van Teeffelen-Heithoff A; Möller HE; Koletzko B; Marquardt T; Rutsch F; Feldmann R
    Mol Genet Metab; 2013; 110 Suppl():S44-8. PubMed ID: 24071437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive functioning in adults with phenylketonuria: Report of a 10-year follow-up.
    Feldmann R; Osterloh J; Onon S; Fromm J; Rutsch F; Weglage J
    Mol Genet Metab; 2019 Mar; 126(3):246-249. PubMed ID: 30598390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of blood phenylalanine levels and IQ in children with phenylketonuria.
    Anastasoaie V; Kurzius L; Forbes P; Waisbren S
    Mol Genet Metab; 2008; 95(1-2):17-20. PubMed ID: 18703366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study.
    Jahja R; Huijbregts SC; de Sonneville LM; van der Meere JJ; Bosch AM; Hollak CE; Rubio-Gozalbo ME; Brouwers MC; Hofstede FC; de Vries MC; Janssen MC; van der Ploeg AT; Langendonk JG; van Spronsen FJ
    Mol Genet Metab; 2013; 110 Suppl():S57-61. PubMed ID: 24183792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study.
    Schindeler S; Ghosh-Jerath S; Thompson S; Rocca A; Joy P; Kemp A; Rae C; Green K; Wilcken B; Christodoulou J
    Mol Genet Metab; 2007 May; 91(1):48-54. PubMed ID: 17368065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Executive function impairment in early-treated PKU subjects with normal mental development.
    Leuzzi V; Pansini M; Sechi E; Chiarotti F; Carducci C; Levi G; Antonozzi I
    J Inherit Metab Dis; 2004; 27(2):115-25. PubMed ID: 15159642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are neuropsychological impairments in children with early-treated phenylketonuria (PKU) related to white matter abnormalities or elevated phenylalanine levels?
    Anderson PJ; Wood SJ; Francis DE; Coleman L; Anderson V; Boneh A
    Dev Neuropsychol; 2007; 32(2):645-68. PubMed ID: 17931123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intellectual, neurologic, and neuropsychologic outcome in untreated subjects with nonphenylketonuria hyperphenylalaninemia. German Collaborative Study on Phenylketonuria.
    Weglage J; Ullrich K; Pietsch M; Fünders B; Güttler F; Harms E
    Pediatr Res; 1997 Sep; 42(3):378-84. PubMed ID: 9284280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood-brain phenylalanine relationships in persons with phenylketonuria.
    Koch R; Moats R; Guttler F; Guldberg P; Nelson M
    Pediatrics; 2000 Nov; 106(5):1093-6. PubMed ID: 11061780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of blood phenylalanine levels on neurocognitive function in adult PKU patients.
    Bartus A; Palasti F; Juhasz E; Kiss E; Simonova E; Sumanszki C; Reismann P
    Metab Brain Dis; 2018 Oct; 33(5):1609-1615. PubMed ID: 29948654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of brain phenylalanine concentration assessed by in vivo proton magnetic resonance spectroscopy in phenylketonuria.
    Leuzzi V; Bianchi MC; Tosetti M; Carducci CL; Carducci CA; Antonozzi I
    J Inherit Metab Dis; 2000 Sep; 23(6):563-70. PubMed ID: 11032331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurocognitive and neuroimaging outcome of early treated young adult PKU patients: A longitudinal study.
    Nardecchia F; Manti F; Chiarotti F; Carducci C; Carducci C; Leuzzi V
    Mol Genet Metab; 2015; 115(2-3):84-90. PubMed ID: 25952249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Social-cognitive functioning and social skills in patients with early treated phenylketonuria: a PKU-COBESO study.
    Jahja R; van Spronsen FJ; de Sonneville LMJ; van der Meere JJ; Bosch AM; Hollak CEM; Rubio-Gozalbo ME; Brouwers MCGJ; Hofstede FC; de Vries MC; Janssen MCH; van der Ploeg AT; Langendonk JG; Huijbregts SCJ
    J Inherit Metab Dis; 2016 May; 39(3):355-362. PubMed ID: 26914933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tackling frontal lobe-related functions in PKU through functional brain imaging: a Stroop task in adult patients.
    Sundermann B; Pfleiderer B; Möller HE; Schwindt W; Weglage J; Lepsien J; Feldmann R
    J Inherit Metab Dis; 2011 Jun; 34(3):711-21. PubMed ID: 21491106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of phenylalanine on cognitive, cerebral, and neurometabolic parameters in adult patients with phenylketonuria (the PICO study): a randomized, placebo-controlled, crossover, noninferiority trial.
    Trepp R; Muri R; Abgottspon S; Bosanska L; Hochuli M; Slotboom J; Rummel C; Kreis R; Everts R
    Trials; 2020 Feb; 21(1):178. PubMed ID: 32054509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the phenylalanine hydroxylase gene on maternal phenylketonuria outcome.
    Güttler F; Azen C; Guldberg P; Romstad A; Hanley WB; Levy HL; Matalon R; Rouse BM; Trefz F; de la Cruz F; Koch R
    Pediatrics; 2003 Dec; 112(6 Pt 2):1530-3. PubMed ID: 14654659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of neuropsychological symptoms of adolescents and adults with PKU.
    Moyle JJ; Fox AM; Arthur M; Bynevelt M; Burnett JR
    Neuropsychol Rev; 2007 Jun; 17(2):91-101. PubMed ID: 17410469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU.
    Diamond A; Prevor MB; Callender G; Druin DP
    Monogr Soc Res Child Dev; 1997; 62(4):i-v, 1-208. PubMed ID: 9421921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of phenylalanine levels on cognitive outcomes in adults with phenylketonuria: Effects across tasks and developmental stages.
    Romani C; Palermo L; MacDonald A; Limback E; Hall SK; Geberhiwot T
    Neuropsychology; 2017 Mar; 31(3):242-254. PubMed ID: 28240926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.